Stevanato Group S.p.A. (NYSE:STVN) Shares Acquired by Wellington Management Group LLP

Wellington Management Group LLP increased its holdings in shares of Stevanato Group S.p.A. (NYSE:STVN - Free Report) by 4.5% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 2,693,588 shares of the company's stock after purchasing an additional 115,050 shares during the quarter. Wellington Management Group LLP's holdings in Stevanato Group were worth $53,872,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Conestoga Capital Advisors LLC raised its stake in shares of Stevanato Group by 5.5% during the third quarter. Conestoga Capital Advisors LLC now owns 7,675,910 shares of the company's stock worth $153,518,000 after purchasing an additional 400,087 shares during the last quarter. Thrivent Financial for Lutherans grew its holdings in Stevanato Group by 67.6% during the third quarter. Thrivent Financial for Lutherans now owns 2,784,912 shares of the company's stock worth $55,698,000 after acquiring an additional 1,123,104 shares during the period. Bamco Inc. NY grew its holdings in Stevanato Group by 1.3% during the third quarter. Bamco Inc. NY now owns 1,685,181 shares of the company's stock worth $33,704,000 after acquiring an additional 21,469 shares during the period. Fred Alger Management LLC grew its holdings in Stevanato Group by 24.2% during the third quarter. Fred Alger Management LLC now owns 1,070,557 shares of the company's stock worth $21,411,000 after acquiring an additional 208,830 shares during the period. Finally, Pembroke Management LTD grew its holdings in Stevanato Group by 143.7% during the third quarter. Pembroke Management LTD now owns 1,051,140 shares of the company's stock worth $21,023,000 after acquiring an additional 619,747 shares during the period.

Stevanato Group Price Performance

Shares of NYSE:STVN traded up €0.36 ($0.38) on Thursday, hitting €22.12 ($23.28). The company had a trading volume of 133,803 shares, compared to its average volume of 499,990. The company has a current ratio of 1.81, a quick ratio of 1.21 and a debt-to-equity ratio of 0.22. Stevanato Group S.p.A. has a 52-week low of €16.56 ($17.43) and a 52-week high of €34.73 ($36.56). The business has a 50 day moving average of €19.53 and a 200 day moving average of €19.63. The company has a market cap of $6.54 billion, a PE ratio of 47.11, a PEG ratio of 9.22 and a beta of 0.59.

Stevanato Group (NYSE:STVN - Get Free Report) last issued its quarterly earnings data on Tuesday, November 5th. The company reported €0.12 ($0.13) earnings per share (EPS) for the quarter, missing the consensus estimate of €0.13 ($0.14) by (€0.01) (($0.01)). Stevanato Group had a net margin of 10.47% and a return on equity of 9.86%. The company had revenue of €277.90 million during the quarter, compared to analysts' expectations of €274.36 million. During the same quarter in the prior year, the company earned $0.16 earnings per share. The firm's revenue was up 2.4% compared to the same quarter last year. As a group, equities analysts anticipate that Stevanato Group S.p.A. will post 0.5 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Separately, Morgan Stanley reissued an "equal weight" rating and issued a $23.00 target price (down previously from $24.00) on shares of Stevanato Group in a report on Tuesday, December 3rd.

About Stevanato Group

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.